Anzeige
Mehr »
Sonntag, 10.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNUE | ISIN: US7995661045 | Ticker-Symbol:
NASDAQ
08.08.25 | 21:59
3,000 US-Dollar
+1,01 % +0,030
1-Jahres-Chart
SANA BIOTECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
SANA BIOTECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur SANA BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSana Biotechnology prices $75 million public offering at $3.35 per share22
DoSana Biotechnology drops 13% on $75M stock issuance, prices at $3.3511
DoSana Biotechnology, Inc: Sana Biotechnology Announces Pricing of Public Offering9
MiSana Biotechnology launches $75 million public offering5
SANA BIOTECHNOLOGY Aktie jetzt für 0€ handeln
MiSana Biotechnology, Inc: Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants4
MiSana Biotechnology, Inc. - 8-K, Current Report8
MoSana Biotechnology, Inc: Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient ...11
01.08.Sana Biotechnology (SANA) Rated 'Market Perform' on Diabetes Program Prospects13
23.07.Citi Maintained a Buy Rating on Sana Biotechnology (SANA)28
02.07.Morgan Stanley initiates Sana Biotechnology stock with Overweight rating107
29.06.Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results17
24.06.H.C. Wainwright maintains buy rating on Sana Biotechnology stock21
24.06.Citizens JMP bekräftigt Bewertung für Sana Biotechnology nach Diabetes-Daten25
24.06.Citizens JMP reiterates Sana Biotechnology stock rating on diabetes data3
23.06.Sana Biotechnology stock soars after positive diabetes treatment results3
23.06.Sana Biotechnology, Inc: Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression367Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate...
► Artikel lesen
23.06.Sana Biotechnology, Inc. - 8-K, Current Report5
09.06.Sana Biotechnology, Inc: Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions9
06.06.Sana Biotechnology, Inc. - 8-K, Current Report13
08.05.Sana Biotechnology, Inc. - S-8, Securities to be offered to employees in employee benefit plans6
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2